[ 3 / biz / cgl / ck / diy / fa / ic / jp / lit / sci / vr / vt ] [ index / top / reports ] [ become a patron ] [ status ]
2023-11: Warosu is now out of extended maintenance.

/sci/ - Science & Math

Search:


View post   

>> No.16149553 [View]
File: 638 KB, 1274x1646, firefox_2024-04-28_08-38-05.jpg [View same] [iqdb] [saucenao] [google]
16149553

>>16148450
the picture you posted shows about the same amount of participants in both randomized groups, but if you want to pick the group with more participants, it would be the group that received the vaccine (21,926 against 21,921).
Another mistake you made when interpreting this table is that you're substituting any event with adverse events. The chart only shows that when you inject someone with a placebo, you get around half as many adverse events as if you had injected them with the covid vaccine (pfizer's). I tried to find in the article you linked what they consider to be an adverse event but it's not made crystal clear to me, I'm not a researcher. However they do make a difference between "reactogenicity" which is up to 7 days after the injection, and adverse events up to 6 months after that first period. What it certainly doesn't count as an adverse event is a covid infection, and the main take away of the article you provided is that the vaccine is considered both safe and efficient. In the appendix, a chart shows that about the rate of severe covid is about 1 to 20-30 in you compare the vaccinated group to the placebo group.

finally, when it comes to death events
>During the blinded, placebo-controlled period, 15 participants in the BNT162b2 group and 14 in the placebo group died; during the open-label period, 3 participants in the BNT162b2 group and 2 in the original placebo group who received BNT162b2 after unblinding died. None of these deaths were considered to be related to BNT162b2 by the investigators. Causes of death were balanced between BNT162b2 and placebo groups (Table S4).

Navigation
View posts[+24][+48][+96]